CG
KDNY

Carmignac Gestion’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Carmignac Gestion’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-56,842
Closed -$2.18M – 173
2023
Q2 		$2.18M Buy
+56,842
New +$2.18M 0.04% 101